Investors
Redalpine
https://redalpine.comRedalpine is a venture capital fund based in Zürich. They support start-ups from early stages like pre-seed and seed through to Series D. With a focus on scalable ICT and Health Tech companies, they have invested in Proxima Fusion and Umiami. Their interests include Mobile, Biotech, and Cybersecurity industries. Redalpine partners with founders to help their startups grow and succeed.
Recent Investments
- LegalFlySeries A( 33 )
- ExpressionEditsSeed( 44 )
- MorressierSeries B( 48 )
- AktiiaSeries A( 41 )
- Proxima FusionSeed( 63 )
- LegalFlySeed( 33 )
- KenjoSeries A( 44 )
- TOLREMO therapeuticsSeries A( 37 )
- KnowunitySeries A( 33 )
- Lakera AISeed( 34 )
- UmiamiSeries A( 52 )
- apaleoSeries A( 28 )
- Hypervision SurgicalSeed( 37 )
- Razor GroupSeries C( 67 )
- CarvolutionSeries D( 37 )
- TaxfixSeries D( 60 )
- Araris BiotechSeries A( 44 )
- 011hSeries A( 40 )
- WhalySeed( 33 )
- EnviriaSeries A( 40 )
- RelaiUnknown( 28 )
- Natif.aiSeed( 28 )
- voizeUnknown( 15 )
- Better DairyUnknown( 52 )
- DaedaleanSeries B( 43 )
- CarvolutionSeries C( 37 )
- Razor GroupSeries B( 67 )
- CollatoSeed( 31 )
- 9finSeries A( 43 )
- felmoSeries B( 37 )
- RelaiSeries A( 28 )
- felmoUnknown( 37 )
- BeamsSeed( 31 )
- MorressierSeries A( 48 )
- LengooSeries B( 40 )
- KenbiUnknown( 37 )
- KenbiSeed( 37 )
- Luya FoodsUnknown( 15 )
- Razor GroupPre Seed( 67 )
- Razor GroupSeed( 67 )
- Razor GroupSeries A( 67 )
- ZenjobSeries B( 50 )
- BnextSeries A( 44 )
- vivenuSeries A( 44 )
- Memo TherapeuticsUnknown( 37 )
- KenjoSeed( 44 )
- MushlabsSeries A( 37 )
- vivenuSeed( 44 )
- TaxfixSeries C( 60 )
- DonutPre Seed( 22 )
- CarvolutionSeries A( 37 )
- Araris BiotechSeed( 44 )
- CarvolutionSeries B( 37 )
- TaxfixSeries B( 60 )
- InkittUnknown( 44 )
- DaedaleanUnknown( 43 )
- BnextUnknown( 44 )
- LengooSeries A( 40 )
- CarvolutionUnknown( 37 )
- PaveUnknown( 33 )
- DonutUnknown( 22 )
- AktiiaSeed( 41 )
- TaxfixSeries A( 60 )
- MorressierSeed( 48 )
- TaxfixSeed( 60 )
- N26Series B( 44 )
- N26Series A( 44 )
- Memo TherapeuticsSeries A( 37 )
- N26Seed( 44 )